Browsing by Subject "Transferrin"

Sort by: Order: Results:

Now showing items 1-2 of 2
  • Zeinoddin, Narjes (Helsingin yliopisto, 2020)
    Endocytosis is the process responsible for internalising membrane components and as such plays a key role in the biology of this structure. Mammalian cells have evolved various endocytic strategies, but Clathrin-Mediated Endocytosis (CME) is the most common type. Since the discovery of CME, around 50 years ago, the field has built a remarkable wealth of knowledge on the core CME components. In stark contrast, our understanding on the relationship between CME and the actin cytoskeleton, which is present throughout the process, is still in its infancy. In this thesis, I show the production and characterisation of recombinant, SpyCatcher tagged transferrin (TF), a canonical CME ligand. TF was expressed in E. coli and using an optimised protocol, successfully solubilised and refolded from inclusion bodies. The protein was then labelled with a fluorophore and purified to a high level of purity. Tests in mammalian cells showed that home-made TF has the same endocytic behaviour as TF purified from human plasma. Moreover, I could show that the SpyCatcher moiety attached to our home-made TF is capable to mediate its covalent linkage to its counterpart SpyTag. The successful production, refolding and functional characterization of recombinant TF in this study is an important first step to examine the participation of the actin cytoskeleton during CME.
  • Pettersson, Tom (2016)
    Anemia on tavallinen ongelma monissa pitkäaikaisissa reumasairauksissa. Tavallisimmat anemian syyt reumasairauksissa ovat tulehdukseen liittyvä raudankäyttöhäiriö sekä ­maha-suolikanavan verenvuodosta johtuva raudanpuute. Raudankäyttöhäiriö johtuu interleukiini 6:n indusoiman hepsidiinin vaikutuksesta raudan kuljetukseen ­suolistossa ja retikuloendoteliaalijärjestelmässä. Tulehduksellista sairautta sairastavan raudanpuute voidaan yleensä tunnistaa määrittämällä seerumin ­ferritiini- ja transferriinireseptoripitoisuus. Tulehdusanemia lievittyy reumasairauden tehokkaalla hoidolla perinteisillä reumalääkkeillä, glukokortikoideilla tai biologisilla lääkkeillä. Itsepintaisen tulehdusanemian hoitoon voidaan harkita rautalääkitystä, jossa parenteraaliset valmisteet ovat etusijalla.